e.g. Tata motors, Reliance MF, 500570

Jagsonpal Pharmaceuticals Ltd. - Research Center

507789 JAGSNPHARM Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 268.72 208.70 236.71 226.10 187.95
Expenses
Material consumed 96.51 80.02 93.18 95.96 80.80
Manufacturing expenses 0.19 0.17 0.29 0.47 0.52
Personnel expenses 64.13 48.49 56.42 57.68 53.98
Selling expenses 17.54 13.86 15.47 12.09 11.83
Adminstrative expenses 39.28 43.09 37.21 34.11 21.73
Expenses capitalised - - - - -
Cost of sales 217.65 185.64 202.56 200.30 168.87
Operating profit 51.07 23.07 34.15 25.79 19.08
Other recurring income 8.19 9.28 5.73 3.34 4.39
Adjusted PBDIT 59.26 32.35 39.89 29.13 23.47
Financial expenses 0.96 0.81 0.41 0.29 1.09
Depreciation 8.13 1.66 1.21 1.53 0.51
Other write offs - - - - -
Adjusted PBT 50.17 29.87 38.27 27.32 21.87
Tax charges 14.50 7.41 8.09 7.73 4.81
Adjusted PAT 35.67 22.46 30.18 19.59 17.06
Non recurring items 19.91 0.29 -5.01 1.36 0.15
Other non cash adjustments - - - - -
Reported net profit 55.58 22.75 25.17 20.95 17.21
Earnigs before appropriation 159.77 117.29 94.54 79.53 64.90
Equity dividend 13.23 13.10 - 10.48 2.62
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 146.54 104.19 94.54 69.05 62.28
Close
Add Jagsonpal Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Jagsonpal Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback